Literature DB >> 17612653

Probucol promotes endogenous antioxidant reserve and confers protection against reperfusion injury.

Dinender K Singla1, Kuljeet Kaur, Anita K Sharma, Sanjiv Dhingra, Pawan K Singal.   

Abstract

The present study examines whether a subchronic probucol treatment of rats offers protection against ischemia-reperfusion (IR) injury in isolated perfused hearts. Sprague-Dawley rats were treated every second day per week with probucol (cumulative dose 120 mg/kg body mass, i.p.) for 4 weeks. In the probucol group, baseline myocardial antioxidant enzyme, glutathione peroxidase (GSHPx), activity was increased (p<0.05), whereas superoxide dismutase (SOD) and catalase (CAT) activities were not changed. Baseline oxidative stress, as indicated by the myocardial lipid peroxidation, was less (p<0.05) in the probucol group. Isolated hearts were subjected to 60 min global I and 20 min R. Recovery of the contractile function in globally ischemic hearts upon reperfusion was 36% in untreated group and 74% in the probucol group. After IR, GSHPx and CAT activities were significantly (p<0.05) higher in the probucol group compared with the control group, whereas SOD did not change. Lipid peroxidation owing to IR was significantly less in the probocol group. These data suggest that probucol treatment improves endogenous antioxidant reserve and protects against increased oxidative stress following IR injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612653     DOI: 10.1139/y06-071

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  9 in total

1.  Cardiac dysfunction subsequent to chronic ozone exposure in rats.

Authors:  Rama Surya Prakash Perepu; David E Dostal; Carlos Garcia; Richard H Kennedy; Rajat Sethi
Journal:  Mol Cell Biochem       Date:  2011-09-27       Impact factor: 3.396

2.  Protective effect of probucol on liver injury induced by carbon tetrachloride in rats.

Authors:  Yu-Tao Zhan; Jing Weng; Li Li; Qing Xu; Xin Song; Xiao-Xia Guo
Journal:  Hepatol Int       Date:  2011-02-10       Impact factor: 6.047

3.  Effect of thrombin fragment (TP508) on myocardial ischemia reperfusion injury in a model of type 1 diabetes mellitus.

Authors:  Louis M Chu; Robert M Osipov; Michael P Robich; Jun Feng; Michael R Sheller; Frank W Sellke
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

Review 4.  Antioxidant therapies for the management of atrial fibrillation.

Authors:  Tong Liu; Panagiotis Korantzopoulos; Guangping Li
Journal:  Cardiovasc Diagn Ther       Date:  2012-12

5.  Effect of thrombin fragment (TP508) on myocardial ischemia-reperfusion injury in hypercholesterolemic pigs.

Authors:  Robert M Osipov; Michael P Robich; Jun Feng; Richard T Clements; Yuhong Liu; Hilary P Glazer; John Wagstaff; Cesario Bianchi; Frank W Sellke
Journal:  J Appl Physiol (1985)       Date:  2009-04-16

6.  Enhanced death signaling in ozone-exposed ischemic-reperfused hearts.

Authors:  Rama Surya Prakash Perepu; Carlos Garcia; David Dostal; Rajat Sethi
Journal:  Mol Cell Biochem       Date:  2009-10-03       Impact factor: 3.396

7.  N-acetylcysteine-enhanced contrast provides cardiorenal protection.

Authors:  Markus Meyer; Martin M LeWinter; Stephen P Bell; Zengyi Chen; Donald E Selby; Dinender K Singla; Harold L Dauerman
Journal:  JACC Cardiovasc Interv       Date:  2009-03       Impact factor: 11.195

8.  Role of oxidative stress versus lipids in monocrotaline-induced pulmonary hypertension and right heart failure.

Authors:  Firoozeh Farahmand; Akshi Malik; Anita Sharma; Ashim K Bagchi; Pawan K Singal
Journal:  Physiol Rep       Date:  2021-11

Review 9.  HSP27 role in cardioprotection by modulating chemotherapeutic doxorubicin-induced cell death.

Authors:  Sivasubramanian Ramani; Sungkwon Park
Journal:  J Mol Med (Berl)       Date:  2021-03-16       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.